Item Type | Name |
Academic Article
|
Complement receptor 3 (CR3, Mac-1, integrin alpha M beta 2, CD11b/CD18) is required for tyrosine phosphorylation of paxillin in adherent and nonadherent neutrophils.
|
Academic Article
|
Complement regulation in the rat glomerulus: Crry and CD59 regulate complement in glomerular mesangial and endothelial cells.
|
Academic Article
|
Moesin, and not the murine functional homologue (Crry/p65) of human membrane cofactor protein (CD46), is involved in the entry of measles virus (strain Edmonston) into susceptible murine cell lines.
|
Academic Article
|
Expression and function of membrane regulators of complement on rat astrocytes in culture.
|
Academic Article
|
The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of function.
|
Academic Article
|
Characterization of C3-binding proteins on mouse neutrophils and platelets.
|
Academic Article
|
Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor.
|
Academic Article
|
Epstein-Barr virus/C3d receptor (CR2, CD21) activated by its extracellular ligands regulates pp105 phosphorylation through two distinct pathways.
|
Academic Article
|
Genetics of the complement system and rheumatic diseases.
|
Academic Article
|
Characterization of rat complement receptors and regulatory proteins. CR2 and Crry are conserved, and the C3b receptor of neutrophils and platelets is distinct from CR1.
|
Academic Article
|
Characterization of a complement receptor 2 (CR2, CD21) ligand binding site for C3. An initial model of ligand interaction with two linked short consensus repeat modules.
|
Academic Article
|
Gamma-glutamyl transpeptidase, an ecto-enzyme regulator of intracellular redox potential, is a component of TM4 signal transduction complexes.
|
Academic Article
|
Renal, central nervous system and pancreatic overexpression of recombinant soluble Crry in transgenic mice. A novel means of protection from complement-mediated injury.
|
Academic Article
|
Complement deficiency states, disease susceptibility, and infection risk in systemic lupus erythematosus.
|
Academic Article
|
Expression of the murine complement regulatory protein crry by glial cells and neurons.
|
Academic Article
|
Regulation of nuclear antigen expression on the cell surface of human monocytes.
|
Academic Article
|
Expression of a soluble complement inhibitor protects transgenic mice from antibody-induced acute renal failure.
|
Academic Article
|
Inhibiting the complement system does not reduce injury in renal ischemia reperfusion.
|
Academic Article
|
Complement inhibitor, complement receptor 1-related gene/protein y-Ig attenuates intestinal damage after the onset of mesenteric ischemia/reperfusion injury in mice.
|
Academic Article
|
The serum resistance of malaria-infected erythrocytes.
|
Academic Article
|
CR2/CD21 proximal promoter activity is critically dependent on a cell type-specific repressor.
|
Academic Article
|
Arthritis critically dependent on innate immune system players.
|
Academic Article
|
Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice.
|
Academic Article
|
The complement system as a therapeutic target in autoimmunity.
|
Academic Article
|
Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury.
|
Academic Article
|
Inhibition of complement activation decreases airway inflammation and hyperresponsiveness.
|
Academic Article
|
Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation.
|
Academic Article
|
Administration of the soluble complement inhibitor, Crry-Ig, reduces inflammation and aquaporin 4 expression in lupus cerebritis.
|
Academic Article
|
Complement activation is critical to airway hyperresponsiveness after acute ozone exposure.
|
Academic Article
|
Overexpression of complement inhibitor Crry does not prevent cryoglobulin-associated membranoproliferative glomerulonephritis.
|
Academic Article
|
Anti-phospholipid antibodies restore mesenteric ischemia/reperfusion-induced injury in complement receptor 2/complement receptor 1-deficient mice.
|
Academic Article
|
Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion.
|
Academic Article
|
Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury.
|
Academic Article
|
Extended flexible linker structures in the complement chimaeric conjugate CR2-Ig by scattering, analytical ultracentrifugation and constrained modelling: implications for function and therapy.
|
Academic Article
|
Factor B of the alternative complement pathway regulates development of airway hyperresponsiveness and inflammation.
|
Academic Article
|
Characterization of human complement receptor type 2 (CR2/CD21) as a receptor for IFN-alpha: a potential role in systemic lupus erythematosus.
|
Academic Article
|
Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis.
|
Academic Article
|
Complement is an essential component of the immune response to adeno-associated virus vectors.
|
Academic Article
|
Antibodies to citrullinated proteins: pathogenic and diagnostic significance.
|
Academic Article
|
The spectrum of complement alternative pathway-mediated diseases.
|
Academic Article
|
A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury.
|
Academic Article
|
Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement.
|
Academic Article
|
The gene encoding decay-accelerating factor (DAF) is located in the complement-regulatory locus on the long arm of chromosome 1.
|
Academic Article
|
Normal polymorphic variations and transcription of the decay accelerating factor gene in paroxysmal nocturnal hemoglobinuria cells.
|
Academic Article
|
Complement activation pathways in murine immune complex-induced arthritis and in C3a and C5a generation in vitro.
|
Academic Article
|
Aseptic injury to epithelial cells alters cell surface complement regulation in a tissue specific fashion.
|
Academic Article
|
The complement inhibitors Crry and factor H are critical for preventing autologous complement activation on renal tubular epithelial cells.
|
Academic Article
|
The regulators of complement activation (RCA) gene cluster.
|
Academic Article
|
Structural studies in solution of the recombinant N-terminal pair of short consensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C3dg.
|
Academic Article
|
Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases.
|
Academic Article
|
CD4+ T cells and complement independently mediate graft ischemia in the rejection of mouse orthotopic tracheal transplants.
|
Academic Article
|
Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr mice.
|
Academic Article
|
Characterization of the human complement receptor 2 (CR2, CD21) promoter reveals sequences shared with regulatory regions of other developmentally restricted B cell proteins.
|
Academic Article
|
Solution structure of TT30, a novel complement therapeutic agent, provides insight into its joint binding to complement C3b and C3d.
|
Academic Article
|
The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment.
|
Academic Article
|
Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1.
|
Academic Article
|
Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity.
|
Academic Article
|
Rheumatoid arthritis is associated with signaling alterations in naturally occurring autoreactive B-lymphocytes.
|
Academic Article
|
Identification of a third component of complement-binding glycoprotein of human platelets.
|
Academic Article
|
Prevention of collagen-induced arthritis in mice transgenic for the complement inhibitor complement receptor 1-related gene/protein y.
|
Academic Article
|
Excessive matrix accumulation in the kidneys of MRL/lpr lupus mice is dependent on complement activation.
|
Academic Article
|
Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2.
|
Academic Article
|
CD59 homologue regulates complement-dependent cytolysis of rat Schwann cells.
|
Academic Article
|
CD21 augments antigen presentation in immune individuals.
|
Academic Article
|
Mutational analysis of the complement receptor type 2 (CR2/CD21)-C3d interaction reveals a putative charged SCR1 binding site for C3d.
|
Academic Article
|
Solution structure of the complex between CR2 SCR 1-2 and C3d of human complement: an X-ray scattering and sedimentation modelling study.
|
Academic Article
|
Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection.
|
Academic Article
|
Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells.
|
Academic Article
|
CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues.
|
Academic Article
|
Complement receptors.
|
Academic Article
|
Complement is activated in kidney by endotoxin but does not cause the ensuing acute renal failure.
|
Academic Article
|
Reduced neuronal cell death after experimental brain injury in mice lacking a functional alternative pathway of complement activation.
|
Academic Article
|
A site in the complement receptor 2 (CR2/CD21) silencer is necessary for lineage specific transcriptional regulation.
|
Academic Article
|
Structure of the Epstein-Barr virus major envelope glycoprotein.
|
Academic Article
|
A molecular and immunochemical characterization of mouse CR2. Evidence for a single gene model of mouse complement receptors 1 and 2.
|
Academic Article
|
Epitope mapping using the X-ray crystallographic structure of complement receptor type 2 (CR2)/CD21: identification of a highly inhibitory monoclonal antibody that directly recognizes the CR2-C3d interface.
|
Academic Article
|
The extended multidomain solution structures of the complement protein Crry and its chimeric conjugate Crry-Ig by scattering, analytical ultracentrifugation and constrained modelling: implications for function and therapy.
|
Academic Article
|
The alternative pathway of complement in disease: opportunities for therapeutic targeting.
|
Academic Article
|
Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis.
|
Academic Article
|
A complement C3 inhibitor specifically targeted to sites of complement activation effectively ameliorates collagen-induced arthritis in DBA/1J mice.
|
Academic Article
|
Molecular basis of the interaction between complement receptor type 2 (CR2/CD21) and Epstein-Barr virus glycoprotein gp350.
|
Academic Article
|
Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury.
|
Academic Article
|
Isolating the Epstein-Barr virus gp350/220 binding site on complement receptor type 2 (CR2/CD21).
|
Academic Article
|
Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells.
|
Academic Article
|
The interrelationship of complement-activation fragments and angiogenesis-related factors in early pregnancy and their association with pre-eclampsia.
|
Academic Article
|
A molecular insight into complement evasion by the staphylococcal complement inhibitor protein family.
|
Academic Article
|
Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice.
|
Academic Article
|
Delineation of the complement receptor type 2-C3d complex by site-directed mutagenesis and molecular docking.
|
Academic Article
|
The alternative pathway is required, but not alone sufficient, for retinal pathology in mouse laser-induced choroidal neovascularization.
|
Academic Article
|
Systemic human CR2-targeted complement alternative pathway inhibitor ameliorates mouse laser-induced choroidal neovascularization.
|
Academic Article
|
CR2-mediated targeting of complement inhibitors: bench-to-bedside using a novel strategy for site-specific complement modulation.
|
Academic Article
|
Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF).
|
Academic Article
|
Therapeutic inhibition of the alternative complement pathway attenuates chronic EAE.
|
Academic Article
|
Oxidative stress sensitizes retinal pigmented epithelial (RPE) cells to complement-mediated injury in a natural antibody-, lectin pathway-, and phospholipid epitope-dependent manner.
|
Academic Article
|
Detection of complement activation using monoclonal antibodies against C3d.
|
Concept
|
Homeodomain Proteins
|
Concept
|
Cytoskeletal Proteins
|
Concept
|
Adaptor Proteins, Signal Transducing
|
Concept
|
Membrane Proteins
|
Concept
|
DNA-Binding Proteins
|
Concept
|
Oncogene Proteins, Fusion
|
Concept
|
Complement C3b Inactivator Proteins
|
Concept
|
ADAM Proteins
|
Concept
|
HSP40 Heat-Shock Proteins
|
Concept
|
GTP-Binding Proteins
|
Concept
|
Recombinant Fusion Proteins
|
Concept
|
Opsonin Proteins
|
Concept
|
Carrier Proteins
|
Concept
|
Proto-Oncogene Proteins c-bcl-2
|
Concept
|
Nuclear Proteins
|
Concept
|
Recombinant Proteins
|
Concept
|
Microfilament Proteins
|
Concept
|
Viral Matrix Proteins
|
Concept
|
Acute-Phase Proteins
|
Concept
|
Mutant Proteins
|
Concept
|
Extracellular Matrix Proteins
|
Concept
|
Intracellular Signaling Peptides and Proteins
|
Concept
|
Complement Inactivator Proteins
|
Concept
|
Retroviridae Proteins, Oncogenic
|
Concept
|
Blood Proteins
|
Concept
|
Viral Envelope Proteins
|
Concept
|
Nerve Tissue Proteins
|
Concept
|
RNA-Binding Proteins
|
Concept
|
Intercellular Signaling Peptides and Proteins
|
Concept
|
Repressor Proteins
|
Concept
|
Immediate-Early Proteins
|
Concept
|
Complement System Proteins
|
Concept
|
Proteins
|
Academic Article
|
Human C3 glomerulopathy provides unique insights into complement factor H-related protein function.
|
Academic Article
|
Complement activation and mortality during an acute episode of thrombotic thrombocytopenic purpura.
|
Academic Article
|
Autoimmunity to citrullinated proteins and the initiation of rheumatoid arthritis.
|
Academic Article
|
Complement and its receptors: new insights into human disease.
|
Academic Article
|
Deficiency of complement receptors CR2/CR1 in Cr2?/? mice reduces the extent of secondary brain damage after closed head injury.
|
Academic Article
|
Human C3b- and C4b-regulatory proteins: a new multi-gene family.
|
Academic Article
|
Targeting pathogenic postischemic self-recognition by natural IgM to protect against posttransplantation cardiac reperfusion injury.
|
Academic Article
|
Analysis of tandem E-box motifs within human Complement receptor 2 (CR2/CD21) promoter reveals cell specific roles for RP58, E2A, USF and localized chromatin accessibility.
|
Academic Article
|
Modulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake.
|
Academic Article
|
The relationship of circulating proteins in early pregnancy with preterm birth.
|
Academic Article
|
Site-targeted complement inhibition by a complement receptor 2-conjugated inhibitor (mTT30) ameliorates post-injury neuropathology in mouse brains.
|
Academic Article
|
New therapeutic and diagnostic opportunities for injured tissue-specific targeting of complement inhibitors and imaging modalities.
|
Academic Article
|
A molecular signature of preclinical rheumatoid arthritis triggered by dysregulated PTPN22.
|
Academic Article
|
Mapping the Complement Factor H-Related Protein 1 (CFHR1):C3b/C3d Interactions.
|
Academic Article
|
Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo.
|
Grant
|
Mouse Membrane RCA Proteins in the Immune Response
|
Grant
|
C3d/EBV Receptor Ligand Binding Sites
|
Grant
|
Disconnecting CR2/CD21 from Its C3d Ligand to Ameliorate Lupus
|
Grant
|
Complement in the Pathogenesis of Autoimmune Arthritis
|
Academic Article
|
Deconstructing the Lectin Pathway in the Pathogenesis of Experimental Inflammatory Arthritis: Essential Role of the Lectin Ficolin B and Mannose-Binding Protein-Associated Serine Protease 2.
|
Academic Article
|
The Evolving Landscape for Complement Therapeutics in Rheumatic and Autoimmune Diseases.
|
Academic Article
|
Association of Antibodies to Citrullinated Protein Antigens with Blood Pressure in First-Degree Relatives of Rheumatoid Arthritis Patients: The Studies of the Etiology of Rheumatoid Arthritis.
|
Academic Article
|
Modulation of the Alternative Pathway of Complement by Murine Factor H-Related Proteins.
|
Academic Article
|
Complement in the Initiation and Evolution of Rheumatoid Arthritis.
|
Academic Article
|
Endothelial Microparticles and Systemic Complement Activation in Patients With Chronic Kidney Disease.
|
Academic Article
|
Autoantibodies against Neurologic Antigens in Nonneurologic Autoimmunity.
|
Concept
|
Ataxia Telangiectasia Mutated Proteins
|
Concept
|
Myxovirus Resistance Proteins
|
Academic Article
|
Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD55.
|
Academic Article
|
Complement and its environmental determinants in the progression of human rheumatoid arthritis.
|
Academic Article
|
Heightened Levels of Antimicrobial Response Factors in Patients With Rheumatoid Arthritis.
|
Academic Article
|
Complement Activation in the Vitreous of Patients With Proliferative Diabetic Retinopathy.
|
Grant
|
Complement in the Pathogenesis of Autoimmune Arthritis
|
Academic Article
|
C2 IgM Natural Antibody Enhances Inflammation and Its Use in the Recombinant Single Chain Antibody-Fused Complement Inhibitor C2-Crry to Target Therapeutics to Joints Attenuates Arthritis in Mice.
|
Academic Article
|
Natural antibody and complement activation characterize patients with idiopathic nephrotic syndrome.
|
Academic Article
|
Insights Into the Structure-Function Relationships of Dimeric C3d Fragments.
|
Academic Article
|
Correlation of Complement Activation in Aqueous and Vitreous in Patients With Proliferative Diabetic Retinopathy.
|
Academic Article
|
Analysis of Complement Gene Expression, Clinical Associations, and Biodistribution of Complement Proteins in the Synovium of Early Rheumatoid Arthritis Patients Reveals Unique Pathophysiologic Features.
|
Academic Article
|
Development and Optimization of Bifunctional Fusion Proteins to Locally Modulate Complement Activation in Diseased Tissue.
|
Academic Article
|
Factor H related proteins modulate complement activation on kidney cells.
|
Academic Article
|
Complement: The Road Less Traveled.
|
Academic Article
|
Contributions of animal models to mechanistic understandings of antibody-dependent disease and roles of the amplification loop.
|
Academic Article
|
Systematic review of type 1 diabetes biomarkers reveals regulation in circulating proteins related to complement, lipid metabolism, and immune response.
|
Academic Article
|
Complement therapeutics are coming of age in rheumatology.
|
Academic Article
|
Systematic review of type 1 diabetes biomarkers reveals regulation in circulating proteins related to complement, lipid metabolism, and immune response.
|
Academic Article
|
Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins.
|
Grant
|
Role of the Factor H Related Proteins in Kidney Disease
|